A study to evaluate the effect of letrozole and tamoxifen on bone and lipids in postmenopausal women with breast cancer

Trial Profile

A study to evaluate the effect of letrozole and tamoxifen on bone and lipids in postmenopausal women with breast cancer

Completed
Phase of Trial: Phase III

Latest Information Update: 06 Mar 2017

At a glance

  • Drugs Letrozole (Primary) ; Tamoxifen
  • Indications Early breast cancer
  • Focus Pharmacodynamics
  • Sponsors Novartis
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 01 Jun 2012 Additional location (England) added and additional lead trial centres identified as reported by ClinicalTrials.gov.
    • 01 Jun 2012 Actual end date (Mar 2011) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top